ForeSight™ Tissue Oximetry Sensor

Tissue oximetry monitoring with ForeSight™ Sensor.

ForeSight™ Tissue Oximetry Sensor
Loading
Overview

The right monitoring makes a difference – for all your patients' differences

The ForeSight™ Tissue Oximetry Sensor provides tissue oximetry and haemodynamic information that may assist clinicians in monitoring cerebral oxygenation for a diverse patient population, all available on one monitor.


ForeSight™ Tissue Oximetry Sensor:

  • Accounts for patient-to-patient differences, including skin tone, size, age, scalp-to-cortex distance and acuity
  • Delivers absolute StO2 values, making a preinduction baseline optional
  • Measures relative change in total tissue haemoglobin, providing additional information relating to StO₂ trends and changes
  • Integrates with the HemoSphere™ platform to display tissue oximetry and haemodynamic information on a single monitor

With ForeSight™ Sensor, you can have tissue oximetry information that may support clinical assessment and decision-making.

The ForeSight™ Sensor Difference

  • Absolute, actionable tissue oximetry measures

  • Across a diverse patient population

  • As part of a complete haemodynamic profile

Designed for Patient Diversity

A tissue oximetry sensor designed with patient differences in mind

Due to the limitations in some other tissue oximetry sensor designs, patient differences including melanin or bilirubin concentrations, cranial thickness, etc., can cloud the accuracy – and therefore the reliability – of oxygenation measures.

With a unique sensor design and exclusive fifth wavelength of near infrared light (NIRS), ForeSight sensor is designed to account for patient differences such as skin pigmentation and scalp-to-cortex distance.

Study shows ForeSight™ Sensor accounts for individual differences in melanin
Sun study high-res

Figure 1. Preoperative tissue oximetry, Sun et. al.

In conventional two-wavelength tissue oximetry systems, skin pigmentation has been shown to interfere with the clinical measurement of regional cerebral oxygen saturation.1

See the study

<p>Figure 2. Foresight sensor readings by race, Stannard et. al.</p>

Figure 2. Foresight sensor readings by race, Stannard et. al.

Tissue oxygenation monitoring using a fifth wavelength of NIRS has been shown to accommodate for the melanin present in a patient’s skin.2

See the study

ForeSight™ Sensors is designed with a penetration depth of approximately 2.5 cm.

Research shows that a 2 cm depth of penetration is insufficient for accurate measurement of StO2 in adult cardiac patients with a deeper scalp-to-cortex distance. But ForeSight™ Sensors is designed to penetrate deeper. At 2.5 cm, ForeSight™ Sensors is designed to provide tissue oximetry measurements in patients with greater scalp-to-cortex distance.

Understanding the role of melanin in tissue oximetry

Model Number

Model

Description

FSESL

ForeSight™ Elite large sensor (≥40 kg), 20 sensors/box

References
  1. Sun X, Ellis J, Corso PJ, Hill PC, Chen F, Lindsay J. Skin pigmentation interferes with the clinical measurement of regional cerebral oxygen saturation. Br J Anaesth. 2015;114(2):276-280. doi:10.1093/bja/aeu335
  2. Stannard B, Levin MA, Lin HM, Weiner MM. Regional cerebral oximetry is consistent across self-reported racial groups and predicts 30-day mortality in cardiac surgery: a retrospective analysis. J Clin Monit Comput. 2021;35(2):413-421. doi:10.1007/s10877-020-00487-x
Absolute tissue oximetry measurements and physiological monitoring information.

The realities of the operating room don’t always allow for the opportunity to set a preinduction baseline – but with ForeSight™ Sensor you can start monitoring without delay.
ForeSight™ Sensor provides continuous, absolute StO2 readings without the need for a preinduction baseline – while still giving you the freedom to set treatment thresholds and trend from a patient baseline.

In addition to StO2 measurements, ForeSight™ Sensor trends the relative change in total tissue haemoglobin (ΔctHb). The ΔctHb parameter provides additional information relating to StO₂ trends and tissue oxygenation changes.

ForeSight™ Sensor algorithms are calibrated and validated to both cerebral and somatic regions:

  • Cerebral oximetry SctO2 calibrated and validated to SjvO2
  • Somatic oximetry SmtO2 calibrated and validated to ScvO2

Additionally, you can view regional oxygenation values specific to sensor location via HemoSphere advanced monitoring platform.

Because ForeSight™ Sensor integrates with HemoSphere™ Advanced Monitoring Platform, you get more than numbers—you get displayed tissue oximetry and haemodynamic information to support clinical assessment.

According to published studies, cerebral desaturations are:

  • ForeSight IQ icons-10

    Common

    Mean desatuation incidence across studies1-9

  • ForeSight IQ icons-11

    Critical

    Linked to increase risk of cognitive dysfunction, 4 POCD10 and mortality11

  • ForeSight IQ icons-12

    Treatable

    Reversing or avoiding cerebral desaturations has been shown to reduce incidence of cognitive impairment,12 ICU stay1 and hosptial stay1

References
  1. Schön J, et al. Cerebral oxygen saturation monitoring in on-pump cardiac surgery – A 1 year experience. Appl Cardiopulm Pathophysiol. 2009;13:243-252.
  2. Yao FSF, et al. Cerebral oxygen desaturation is associated with early postoperative neuropsychological dysfunction in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18(5):552-558. doi:10.1053/j.jvca.2004.07.007
  3. Murkin JM, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104(1):51-58. doi:10.1213/01.ane.0000246814.29362.f4
  4. de Tournay-Jetté E, et al. The relationship between cerebral oxygen saturation changes and postoperative cognitive dysfunction in elderly patients after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2011;25(1):95-104. doi:10.1053/j.jvca.2010.03.019
  5. Deschamps A, et al. Reversal of decreases in cerebral saturation in high-risk cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27(6):1260-1266. doi:10.1053/j.jvca.2013.01.019
  6. Greenberg SB, et al. Cerebral desaturation events in the intensive care unit following cardiac surgery. J Crit Care. 2013;28(3):270-276. doi:10.1016/j.jcrc.2012.09.004
  7. Deschamps A, et al. Cerebral oximetry monitoring to maintain normal cerebral oxygen saturation during high-risk cardiac surgery: a randomized controlled feasibility trial. Anesthesiology. 2016;124(4):826-836. doi:10.1097/ALN.0000000000001029
  8. Subramanian B, et al. A multicenter pilot study assessing regional cerebral oxygen desaturation frequency during cardiopulmonary bypass and responsiveness to an intervention algorithm. Anesth Analg. 2016;122(6):1786-1793. doi:10.1213/ANE.0000000000001275
  9. Uysal S, et al. Optimizing cerebral oxygenation in cardiac surgery: a randomized controlled trial examining neurocognitive and perioperative outcomes. J Thorac Cardiovasc Surg. 2020;159(3):943-953. doi:10.1016/j.jtcvs.2019.03.036
  10. Slater JP, et al. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009;87(1):36-45. doi:10.1016/j.athoracsur.2008.08.070
  11. Stannard B, et al. Regional cerebral oximetry is consistent across self-reported racial groups and predicts 30-day mortality in cardiac surgery: a retrospective analysis. J Clin Monit Comput. 2021;35(2):413-421. doi:10.1007/s10877-020-00487-x
  12. Colak Z, et al. Influence of intraoperative cerebral oximetry monitoring on neurocognitive function after coronary artery bypass surgery: a randomized, prospective study. Eur J Cardiothorac Surg. 2015;47(3):447-454. doi:10.1093/ejcts/ezu193
All-in-one monitoring

One monitor, comprehensive insights

Tissue oximetry measures are only one part of a surgical patient’s haemodynamic profile.
That’s why the ForeSight™ System is available as part of the HemoSphere™ Advanced monitoring platform – providing an integrated display of tissue oximetry and haemodynamic parameters on a single monitoring platform.
This “all-in-one” view delivers comprehensive insights into patient perfusion that may support assessment of haemodynamic and tissue oxygenation trends – supporting clinical assessment and decision-making.

Learn More

ForeSight™ System delivers tissue oximetry insights via HemoSphere™ advanced monitoring platform

Also available with HemoSphere™ monitor

Acumen Hypotension Prediction Index™ (HPI) software

This first-of-its-kind predictive software alerts you to the likelihood of a patient trending toward hypotension – and provides information relating to haemodynamic status that may assist clinicians in monitoring patients at risk of hypotension.

Discover Acumen HPI™ Software

ForeSight Jr™ Tissue Oximetry Sensor

ForeSight Jr™ Sensor is different by design—providing tissue oximetry information to support clinical assessment.

Explore ForeSight Jr™ Sensor

Resources

Let's have a conversation

Fill out our form to have one of our haemodynamics specialists contact you.

true
true
ForeSight™ Tissue Oximetry Sensor /content/dam/bd-assets/bd-com/en-us/images/product-family/advanced-patient-monitoring/flotrac/flotrac-sensor-thumb.jpg BD Advanced hemodynamic sensors and catheters ForeSight™ sensor ForeSight™

Acumen Hypotension Prediction Index™ (HPI) software

,

This first-of-its-kind predictive software alerts you to the likelihood of a patient trending toward hypotension – and provides information relating to haemodynamic status that may assist clinicians in monitoring patients at risk of hypotension.

Discover Acumen HPI™ Software

,

ForeSight Jr™ Tissue Oximetry Sensor

,

ForeSight Jr™ Sensor is different by design—providing tissue oximetry information to support clinical assessment.

Explore ForeSight Jr™ Sensor

/content/dam/bd-assets/bd-com/en-us/logos/bd/header-bd-logo.svg

Tissue oximetry monitoring with ForeSight™ Sensor.

bar000280 Sherlock 3CG+™ Display Rollstand Mounting Bracket amp09us Sherlock™ Standalone Display Remote Control 9770655 Sherlock 3CG+™ Tip Confirmation System The Sherlock 3CG+™ TCS is indicated as an alternative method to chest X-ray and fluoroscopy for CVAD tip placement, eliminating harmful radiation 9770371 Sherlock 3CG+™ Display - ROW 9770361 Sherlock 3CG+™ Display - CE 9770358 Sherlock 3CG+™ Large Sensor 9770353 Sherlock 3CG+™ Small Sensor 9770351 Sherlock 3CG+™ Display - US 9770338 Sherlock 3CG+™ Tip Confirmation System The Sherlock 3CG+™ TCS is indicated as an alternative method to chest X-ray and fluoroscopy for CVAD tip placement, eliminating harmful radiation